Ordina N.V. : No turn-around in sight
Entry price | Target | Stop-loss | Potential |
---|
€4.4 |
€4.82 |
€4.18 |
+9.67% |
---|
Shares in Ordina N.V. do not show any sign of a slowdown in the ascending dynamic. Investors could bet on a continuation of the underlying trend.
Summary● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths● The company is in a robust financial situation considering its net cash and margin position.
● The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
● The company has a low valuation given the cash flows generated by its activity.
● This company will be of major interest to investors in search of a high dividend stock.
● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.